This Week in Cardiology

• Feb 23 2024 This Week in Cardiology   Reading incidental CAC on chest CT scans, exercise benefits in women vs men, PCI with or without imaging, and trial non-reporting are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, February 23, 2024
• Feb 16 2024 This Week in Cardiology   An update in trial interpretation, CI, and P-values; percutaneous tricuspid Interventions; and news on HDL and humility in Medicine are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, February 16, 2024
• Feb 09 2024 This Week in Cardiology   Beta-blocker withdrawal in HFpEF, the ARCADIA trial, food as medicine, and bariatric surgery are the topics John Mandrola, MD, discusses in today's podcast.
  theheart.org on Medscape, February 09, 2024
• Feb 02 2024 This Week in Cardiology   FDA approves PFA for AF ablation, flawed comparisons of TEER vs MV surgery and PCI vs CABG, and cardiologists struggling with board exams are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, February 02, 2024
• Jan 26 2024 This Week in Cardiology   LAAO, more evidence that stable CAD is stable, CRT benefit over the long-term, and AF monitoring after stroke are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, January 26, 2024
• Jan 19 2024 This Week in Cardiology   Listener feedback on antiplatelet therapy after PCI, bempedoic acid, off-Label PFO Closure, and palliative care are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, January 19, 2024
• Jan 12 2024 This Week in Cardiology   GLP-1s and BaroStim Neo revisited, a new drug for transthyretin amyloid CM, clopidogrel vs ASA years after PCI and stent, and statins are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, January 12, 2024
• Jan 05 2024 This Week in Cardiology   Neuro-modulation in HF, private equity owned hospitals, HCM, SCD and ICD re-evaluated, and peer review are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, January 05, 2024
• Dec 15 2023 This Week in Cardiology   FDA approves PFA, breakthrough in PAH, residual leaks after percutaneous LAAO, OAC in low-intermediate risk people are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, December 15, 2023
• Dec 08 2023 This Week in Cardiology   Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, December 08, 2023
• Dec 01 2023 This Week in Cardiology   More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 01, 2023
• Nov 17 2023 This Week in Cardiology   An AHA Recap: SELECT, ORBITA2, and ARTESIA are the trials John Mandrola, MD, reviews in this week’s podcast.
  theheart.org on Medscape, November 17, 2023
• Nov 10 2023 This Week in Cardiology   Renal denervation, a potential deadly decision in the ED, GLP-1 agonists, and an AHA preview are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, November 10, 2023
• Nov 03 2023 This Week in Cardiology   Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, November 03, 2023
• Oct 27 2023 This Week in Cardiology   More on the Million Hearts RCT, ENRICH AF, TAVI vs SAVR, the Partner 3 and Evolut-low-risk trials, and myocardial viability are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, October 27, 2023
• Oct 20 2023 This Week in Cardiology   Listener feedback, oral anticoagulation in patients with ICH, an example of statistical significance but not clinical significance, and statins and diabetes are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, October 20, 2023
• Oct 13 2023 This Week in Cardiology   Three stories regarding GLP-1 agonists, imaging during PCI, and the power of sham controls in procedure trials are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, October 13, 2023
• Oct 06 2023 This Week in Cardiology   Coated vs uncoated ASA, a new trial in CAD, conflicts of interest, first AF in the hospital, and changing HTN scoring and CHADSVASC are the topics John Mandrola, MD, covers in this week's podcast.
  theheart.org on Medscape, October 06, 2023
• Sep 29 2023 This Week in Cardiology   Reader feedback, leadless pacing, ABIM, SGLT2 inhibitors, peri-operative MI after cardiac surgery, and AHA late-breakers are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, September 29, 2023
• Sep 22 2023 This Week in Cardiology   Coronary calcium, cardiac arrest survival, Factor XI drug findings, APCs and a potential new board certification in cardiology are the topics discussed by John Mandrola, MD in this week’s podcast.
  theheart.org on Medscape, September 22, 2023